| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Revenue | ||||||
7,000 | 5,000 | - | ||||
Operating expenses: | ||||||
Research and development | ||||||
40,166 | 33,046 | 25,745 | ||||
General and administrative | ||||||
13,770 | 10,161 | 5,599 | ||||
Total operating expenses | ||||||
53,936 | 43,207 | 31,344 | ||||
Loss from operations | ||||||
-46,936 | -38,207 | -31,344 | ||||
Other income: | ||||||
Grant income | ||||||
2,300 | 5,337 | 1,396 | ||||
Interest income | ||||||
1,463 | 390 | 25 | ||||
Total other income | ||||||
3,763 | 5,727 | 1,421 | ||||
Loss before income taxes | ||||||
-43,173 | -32,480 | -29,923 | ||||
Provision for income taxes | ||||||
677 | 472 | - | ||||
Net loss | ||||||
-43,850 | -32,952 | -29,923 | ||||
Dividends declared | ||||||
- | 9,142 | - | ||||
Net Loss per Share | ||||||
Net loss attributable to common stockholders—basic and diluted | ||||||
-43,850 | -42,094 | -29,923 | ||||
Net loss per share—basic and diluted (in dollar per share) | ||||||
-3.33 | -12.31 | -13,795.76 | ||||
Weighted average common stock outstanding—basic and diluted (in shares) | ||||||
13,160 | 3,419 | 2 | ||||
Other comprehensive loss: | ||||||
Net loss | ||||||
-43,850 | -42,094 | - | ||||
Net loss | ||||||
-43,850 | -32,952 | -29,923 | ||||
Net unrealized gain on investments held | ||||||
9 | -9 | - | ||||
Comprehensive loss | ||||||
-43,841 | -32,961 | -29,923 | ||||